325P Real-world cabazitaxel survival to inform phase III development of PT-112 in metastatic castration-resistant prostate cancer (mCRPC)

ESMO Real World Data and Digital Oncology · Elsevier

Аннотация

Publication date: November 2026 Source: ESMO Real World Data and Digital Oncology, Volume 14, Supplement Author(s): A.H. Bryce, T.D. Ames, G. Roubaud, E. Castro Marcos, K.L. Ito, E. Scherrer, J. Baeck, J.F. O'Donnell, M. Price, K. Fizazi

Читать у издателя →

Похожие статьи